Senseonics Holdings Soars 7.3% on Eversense 365 Partnership

Senseonics Holdings' stock surged 7.3% in pre-market trading on September 4, 2025, driven by strategic partnerships and commercialization efforts.

Senseonics Holdings has signed a Memorandum of Understanding with Ascensia Diabetes Care to take over the commercialization and distribution of Eversense 365. This agreement will see Senseonics assume responsibility for all global sales, marketing, and commercialization activities in the U.S., aiming to accelerate growth and integrate manufacturing and distribution processes.

This strategic move is expected to redefine Senseonics' financial trajectory, aligning with its goals for margin expansion and sustainable growth. By taking control of Eversense 365's distribution, the company aims to enhance its market presence and operational efficiency, positioning itself for long-term success in the diabetes care market.